0001558370-19-002516 Sample Contracts

FIRST AMENDMENT TO LEASE

Lease • March 28th, 2019 • Rubius Therapeutics, Inc. • Biological products, (no disgnostic substances)

• Contract Type
  Lease
• Filed
  March 28th, 2019
• Company
  Rubius Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)

THIS FIRST AMENDMENT TO LEASE (this “First Amendment”) is made as of November 8, 2018, by and between ARE-MA REGION NO. 58, LLC, a Delaware limited liability company (“Landlord”), and RUBIUS THERAPEUTICS, INC., a Delaware corporation (“Tenant”).

Contract

Rubius Therapeutics, Inc. • March 28th, 2019 • Biological products, (no disgnostic substances)

• Company
  Rubius Therapeutics, Inc.
• Filed
  March 28th, 2019
• Industry
  Biological products, (no disgnostic substances)

This SECOND AMENDMENT, effective as of July 25, 2018 (the “SECOND AMENDMENT EFFECTIVE DATE”), amends the Exclusive Patent License Agreement dated January 28, 2016, and First Amendment dated December 12, 2017 (the “LICENSE”), between the Whitehead Institute for Biomedical Research (“WHITEHEAD”) and Rubius Therapeutics, Inc. (“COMPANY”).